当前位置:首页>>博士后招聘>>国外博士后招聘>>正文内容

美国NIH国家过敏和传染病研究所招聘博士后—免疫学与分子生物学

2026年09月18日
来源:知识人网整理
摘要:

美国NIH国家过敏和传染病研究所招聘博士后—免疫学与分子生物学

Postdoctoral Fellow

Employer

National Institute of Allergy and Infectious Diseases, NIH

Location

Rockville, Maryland

Salary

Trainees will receive health insurance as well as a stipend commensurate with experience.

Closing date

8 Nov 2026

Discipline

Biomedicine

Job Type

Postdoctoral

Employment - Hours

Full time

Duration

Fixed term

Qualification

PhD

Sector

Government

Job Details

Department of Health and Human Services

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Postdoctoral Fellow

Laboratory of Immunogenetics

Antibody Biology Unit

Postdoctoral fellow – antibody discovery against novel malaria sporozoite targets

The Antibody Biology Unit in the Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS) aims to discover therapeutic monoclonal antibodies (mAbs) to combat major pathogens, including malaria, TB and infectious viruses. A postdoctoral position is available in the Antibody Biology Unit, headed by Dr. Joshua Tan, to discover next-generation antibodies targeting the Plasmodium falciparum sporozoite, the parasite form that initiates a malaria infection.

The Tan lab recently identified a new mAb class that targets the pGlu-CSP site on P. falciparum sporozoites and is able to confer sterilizing protection against sporozoite challenge in vivo (Dacon et al., Science 2025). Importantly, these mAbs do not interfere with the current malaria vaccines, RTS,S/AS01 and R21/Matrix M, and they are now lead candidates for development for clinical use to prevent malaria. This study confirmed the utility of using an antigen-agnostic approach to discover antibodies against new malaria targets, and preliminary data from our lab suggests that there could be other antibody targets on the sporozoite surface that have not yet been discovered.

The aim of this postdoctoral project is to use an antigen-agnostic approach to identify mAbs against new (non-CSP) targets on the sporozoite surface, as well as to discover next-generation antibodies against pGlu-CSP for clinical development. Antibody sequences would be analyzed by next-generation sequencing to accelerate mAb discovery and characterization. The anticipated project outcomes are to increase our understanding of the landscape of antibody targets on the sporozoite surface, find new prophylactic mAbs against malaria, and identify new pre-erythrocytic malaria vaccine candidates.

This position is ideal for a candidate with a strong immunology or molecular biology background who is interested in developing new interventions against malaria that could be deployed in a real-world setting. The NIH Intramural Research Program also provides excellent training and career development opportunities.

Qualifications                              

Ph.D. in a relevant field (immunology or molecular biology)

Experience in next-generation sequencing, including setting up barcoded libraries and bioinformatics data analysis for antibody discovery

Track record of scientific publications

Collaborative and willing to work as part of a team

Trainees will receive health insurance as well as a stipend commensurate with experience.

Appointees may be a US citizen, Legal Permanent Resident or non-US citizen (visa requirements apply).

To Apply

Interested candidates should send the following to Joshua Tan, Ph.D., Chief, Antibody Biology Unit, NIAID, NIH at tanj4@nih.gov:

Cover letter

Curriculum vitae

Contact details of three referees


准备申请国外博士后的各位老师注意了!知识人网www.zsrw.cn)小编每周定时更新最新的国内外博士后招聘信息以及访问学者、博士后资讯,感谢大家的关注!